Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral gabapentin to reduce sedative consumption in mechanically ventilated ICU patients
IRCT20190202042588N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gabapentin in ventilator dependence (PMV), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Sedative consumption. Started May 2019; status: completed.
02
Drugs
gabapentin
03
Conditions
ventilator dependence (PMV)
Beyond the preview
Go deeper on IRCT20190202042588N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190202042588N1.